Aminoglycoside-induced balance deficits: a review of vestibulotoxicity

References

• Troost BT, Waller MA. Drug-induced vestibulocochlear toxicity. In: Biller J, ed. Iatrogenic neurology. Boston: Butterworth-Heinemann; 1998: 253–267.
   Google Scholar
• Black FO, Pesznecker SC. Vestibular ototoxicity. Otolaryngol Clin North Am. 1993; 20: 713–736.
   Google Scholar
• Dhanireddy S, Liles WC, Gates GA. Vestibular toxic effects induced by once-daily aminoglycoside therapy. Arch Otolaryngol Head Neck Surg. 2005; 131: 46–48.
   PubMed Web of Science ®Google Scholar
• Lustig LR, Niparko JK. Sensori-neural hearing loss. In: Lustig LR, Niparko JK, eds. Clinical neurotology. London: Martin Dunitz Ltd; 2003: 161–174.
   Google Scholar
• Schacht J. Aminoglycoside antibiotics. In: Campbell KCM, ed. Pharmacology and ototoxicity for audiologists. New York: Thomson Delmar Learning; 2007: 163–176.
   Google Scholar
• Pillers DM, Schleiss MR. Gentamicin in the clinical setting. Volta Rev. 2005; 105: 205–210.
   Web of Science ®Google Scholar
• Zagólski O. Vestibular system in infants after systemic aminoglycoside therapy Int J Ped Otorhinolaryngol. 2007; 71: 1797–1802.
   PubMed Web of Science ®Google Scholar
• Edson RS, Terrell CL. The aminoglycosides. Mayo Clin Proc. 1999; 74: 519–528.
   PubMed Web of Science ®Google Scholar
• Erdeljic V, Francetic I, Macolic-Sarinic V, et al. Evaluation and justification for antibiotic use at the Internal Medicine Clinic of the Clinical Hospital in Zagreb. Acta Med Croatica. 2004; 58: 293–299.
   PubMedGoogle Scholar
• Kumana CR, Yuen KY. Parenteral aminoglycoside therapy: selection, administration and monitoring. Drugs 1994; 47: 902–913.
   PubMed Web of Science ®Google Scholar
• Bennett C. The aminoglycosides. Prim Care Update Obstets Gyn. 1996; 3: 186–191.
   Google Scholar
• Achmat Z, Roberts RA. Steering the storm: TB and HIV in South Africa. A policy paper of the Treatment Action Campaign [homepage on the Internet] c2006. Available from:
   Google Scholar
• http://www.tac.org.za/Documents/TBPaperforConference1.pdf
   Google Scholar
• English WP Williams MD. Should aminoglycoside antibiotics be abandoned? Am J Surg. 2000; 180: 512–516.
   PubMed Web of Science ®Google Scholar
• Matsui JI, Cotanche DA. Sensory hair cell death and regeneration: two halves of the same equation. Curr Opin Otolaryngol Head Neck Surg. 2004; 12: 418–425.
   PubMedGoogle Scholar
• World Health Organisation. Treatment of TB: guidelines for national programmes. 3rd edition. Geneva, Switzerland: WHO; 2003.
   Google Scholar
• Ariano RE, Zelenitsky SA, Kassum DA. Aminoglycoside-induced vestibular injury: maintaining a sense of balance. Ann Pharmacother. 2008; 42: 1282–1289.
   PubMed Web of Science ®Google Scholar
• Mendel B, Bergenius J, Langius A. Dizziness symptom severity and impact on daily living as perceived by patients suffering from peripheral vestibular disorder Clin Otolaryngol Allied Sci. 1999; 24: 286–293.
   Google Scholar
• Wrisley DM, Pavlou M. Physical therapy for balance disorders. Neurol Clin. 2005; 23: 855–874.
   PubMed Web of Science ®Google Scholar
• Brown KE, Whitney SL, Wrisley DM, Furman JM. Physical therapy outcomes for persons with bilateral vestibular loss. Laryngoscope 2001; 111: 1812–1817.
   PubMed Web of Science ®Google Scholar
• Whitney SL, Rossi MM. Efficacy of vestibular rehabilitation. Otolaryngol Clin North Am. 2000; 33: 659–672.
   PubMed Web of Science ®Google Scholar
• Black FO, Pesznecker S, Stallings V. Permanent gentamicin vestibulotoxicity. Otol Neurotology. 2004; 25: 559–569.
   PubMed Web of Science ®Google Scholar
• Smith PF, Zheng Y Horri A, Darlington CL. Does vestibular damage cause cognitive dysfunction in humans? J Vestibular Res. 2005; 15: 1–9.
   PubMed Web of Science ®Google Scholar
• Monzani D, Casolari L, Guidetti G, Rigaletti M. Psychological distress and disability in patients with vertigo. J Psychosom Res. 2001; 50: 319–323.
   PubMed Web of Science ®Google Scholar
• Nakashima T, Teranishi M, Hibi T, et al. Vestibular and cochlear toxicity of aminoglycosides—a review. Acta Otolaryngol. 2000; 120: 904–911.
   PubMed Web of Science ®Google Scholar
• Schwade ND. Pharmacology in audiology practice. In: Roeser RJ, Valente M, Hosford-Dunn H, eds. Audiology diagnosis. New York: Thieme; 2000; p. 139–162.
   Google Scholar
• Kisilevsky VE, Tomlinson RD, Ranalli PJ, Prepageran N. Monitoring vestibular ototoxicity. In: Roland PS, Rutka JA, eds. Ototoxicity. Hamilton, Canada: BC Decker; 2004; p. 161–169.
   Google Scholar
• Schwartz WS. Initial treatment of tuberculosis. In: Phillips S, ed. Current problems in tuberculosis. Springfield, Illinois: Charles C. Thomas; 1966: p. 30–39.
   Google Scholar
• Telzak EE, Sepkowitz KA. Treatment of multi-drug resistant tuberculosis. In: Schlossberg D, ed. Tuberculosis and non-tuberculosis mycobacterial infections. 4th edition. Philadelphia: WB Saunders; 1999; p. 83–92.
   Google Scholar
• Matz GJ. Aminoglycoside ototoxicity. Otolaryngol Clin North Am. 1993; 26: 705–712.
   Web of Science ®Google Scholar
• Lautermann J, Schacht J. Reduced nutritional status enhances ototoxicity Laryngorhinootologie 1995; 74: 724–727.
   Google Scholar
• Rybak MJ, Abate BJ, Kang SL, et al. Prospective evaluation of the effect of an aminoglycoside dosing regimen in rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother. 1999; 43: 1549–1555.
   PubMed Web of Science ®Google Scholar
• Black FO, Gianna-Poulin C, Pesznecker SC. Recovery from ototoxicity. Otol Neurotol 2001; 22: 662–671.
   PubMed Web of Science ®Google Scholar
• Ruckenstein MJ. Vertigo and dysequilibrium associated with hearing loss. Otolaryngol Clin North Am. 2000; 33: 535–562.
   PubMed Web of Science ®Google Scholar
• Rutka J. Physiology of the vestibular system. In: Roland P, Rutka J, eds. Ototoxicity. Hamilton, Canada: BC Decker; 2004: 20–27.
   Google Scholar
• Smith DB. Dizziness: a clinical perspective. Neurol Clin. 1990; 8: 199–207.
   PubMed Web of Science ®Google Scholar
• Rizzi MD, Hirose K. Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg. 2007; 15: 352–357.
   PubMedGoogle Scholar
• Halmagyi GM, Fattore CM, Curthoys IS, Wade S. Gentamicin vestibulotoxicity. Otolaryngol Head Neck Surg. 1994; 111: 571–574.
   PubMed Web of Science ®Google Scholar
• Van der Walt H., Too close for comfort: emotional ties between nurse and patients. In: Swartz L, Gibson K, Gelman T, eds. Reflective practice: psychodynamic ideas in the community. Cape Town, South Africa: Human Sciences Research Council [homepage on the Internet] c2002. Available from http://www.hsrcpress.ac.za/e-library
   Google Scholar
• Freeman S, Priner R, Elidan J, Sohmer H. Objective method for differentiating between drug-induced vestibulotoxicity and ototoxicity. Otol Neurotol. 2001; 22: 70–75.
   PubMed Web of Science ®Google Scholar
• Tsuji K, Rauch SD, Wall III C, et al. Temporal bone studies of the human peripheral system. 3. Aminoglycoside ototoxicity. Ann Otol Rhinol Laryngol. 2000; 109: 20–25.
   Web of Science ®Google Scholar
• Black FO, Pesznecker SC. Vestibular ototoxicity. Otolaryngol Clin North Am. 1993; 20: 713–736.
   Google Scholar
• Arriaga MA, Chen DA, Cenci KA. Rotational chair (ROTO) instead of electronystagmography (ENG) as the primary vestibular test. Otolaryngol Head Neck Surg. 2005; 133: 329–333.
   PubMed Web of Science ®Google Scholar
• Hajioff D, Barr-Hamilton RM, Colledge NR, Lewis SJ, Wilson JA. Is electronystagmography of diagnostic value in the elderly? Clin Otolaryngol Allied Sci 2002; 27: 27–31.
   PubMed Web of Science ®Google Scholar
• Hoffman RM, Einstadter D, Kroenke K. Evaluating dizziness. Am J Med. 1999; 107: 468–478.
   PubMed Web of Science ®Google Scholar
• Fife TD, Tusa RJ, Furman JM, et al. Assessment: vestibular testing techniques in adults and children. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2000; 55: 1431–1441.
   PubMed Web of Science ®Google Scholar
• Hamid, MA. Contemporary neurovestibular physiological assessment. Curr Opin Otolaryngol Head Neck Surg. 2000;8:391–394.
   Google Scholar
• Paydarfar JA, Goebel JA. Integrated clinical and laboratory vestibular evaluation. Curr Opin Otolaryngol Head Neck Surg. 2000; 8: 363–368.
   Google Scholar
• Davies R. Bedside neuro-otological examination and interpretation of comonly used investigations. J Neurol Neurosurg Psychiatry. 2004; 75: iv32–44.
   PubMed Web of Science ®Google Scholar
• Zingler VC, Weintz E, Jahn K, et al. Follow-up of vestibular hypofunction in bilateral vestibulopathy. J Neurol Neurosurg Psychiatry. 2008; 79: 284–288.
   PubMed Web of Science ®Google Scholar
• Hain TC, Yacovino D. Pharmacologic treatment of persons with dizziness. Neurologic Clinics. 2005; 23: 831–853.
   PubMed Web of Science ®Google Scholar
• Shepard NT, Telian SA. Programmatic vestibular rehabilitation. Otolaryngol Head Neck Surg. 1995; 112: 173–182.
   PubMed Web of Science ®Google Scholar
• Luxon LM. Evaluation and management of the dizzy patient. J Neurol Neurosurg Psychiatry. 2004: 75: iv45–52.
   PubMed Web of Science ®Google Scholar
• Gillespie MB, Minor LB. Prognosis in bilateral vestibular hypofunction. Laryngoscope 1999; 109: 35–41.
   PubMed Web of Science ®Google Scholar
• Calder JH, Jacobson GP. Acquired bilateral peripheral vestibular system impairment: rehabilitative options and potential outcomes. J Am Acad Audiol. 2000: 11: 514–521.
   PubMedGoogle Scholar
• Vasquez R, Mattucci KF. A proposed protocol for monitoring ototoxicity in patients who take cochleo- or vestibulotoxic drugs. Ear Nose Throat J. 2003; 82: 181–184.
   PubMedGoogle Scholar
• Roland PS. Characteristics of systemic and topical agents in toxicity of the middle and inner ear. Ear Nose Throat J. 2003; 82(Suppl 1): 3–8.
   PubMedGoogle Scholar
• Roland PS. New developments in our understanding of ototoxicity. Ear Nose Throat J. 2004; 83(Suppl 4):15–17.
   PubMedGoogle Scholar